Synchronized renal tubular cell death involves ferroptosis

Linkermann, A; Skouta, R; Himmerkus, N; Mulay, SR; Dewitz, C; De Zen, F; Prokai, A [Prókai, Ágnes (nefrológus), szerző] I. Sz. Gyermekgyógyászati Klinika (SE / AOK / K); Zuchtriegel, G; Krombach, F; Welz, P-S; Weinlich, R; Berghe, TV; Vandenabeele, P; Pasparakis, M; Bleich, M; Weinberg, JM; Reichel, CA; Bräsen, JH; Kunzendorf, U; Anders, H-J; Stockwell, BR; Green, DR; Krautwald, S

Angol nyelvű Szakcikk (Folyóiratcikk) Tudományos
  • X. Földtudományok Osztálya: A
  • Regionális Tudományok Bizottsága: A nemzetközi
  • Szociológiai Tudományos Bizottság: A nemzetközi
  • SJR Scopus - Multidisciplinary: D1
Azonosítók
Szakterületek:
  • Egyéb természettudományok
Receptor-interacting protein kinase 3 (RIPK3)-mediated necroptosis is thought to be the pathophysiologically predominant pathway that leads to regulated necrosis of parenchymal cells in ischemia-reperfusion injury (IRI), and loss of either Fas-associated protein with death domain (FADD) or caspase-8 is known to sensitize tissues to undergo spontaneous necroptosis. Here, we demonstrate that renal tubules do not undergo sensitization to necroptosis upon genetic ablation of either FADD or caspase-8 and that the RIPK1 inhibitor necrostatin-1 (Nec-1) does not protect freshly isolated tubules from hypoxic injury. In contrast, irondependent ferroptosis directly causes synchronized necrosis of renal tubules, as demonstrated by intravital microscopy in models of IRI and oxalate crystal-induced acute kidney injury. To suppress ferroptosis in vivo, we generated a novel third-generation ferrostatin (termed 16-86), which we demonstrate to be more stable, to metabolism and plasma, and more potent, compared with the firstin- class compound ferrostatin-1 (Fer-1). Even in conditions with extraordinarily severe IRI, 16-86 exerts strong protection to an extent which has not previously allowed survival in any murine setting. In addition, 16-86 further potentiates the strong protective effect on IRI mediated by combination therapy with necrostatins and compounds that inhibit mitochondrial permeability transition. Renal tubules thus represent a tissue that is not sensitized to necroptosis by loss of FADD or caspase-8. Finally, ferroptosis mediates postischemic and toxic renal necrosis, which may be therapeutically targeted by ferrostatins and by combination therapy.
Hivatkozás stílusok: IEEEACMAPAChicagoHarvardCSLMásolásNyomtatás
2024-07-17 22:48